UnitedHealth [UNH] vs CVS Health [CVS] Detailed Stock Comparison
UnitedHealth
NYSE
Loading...
CVS Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: UnitedHealth wins in 15 metrics, CVS Health wins in 5 metrics, with 0 ties. UnitedHealth appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | UnitedHealth | CVS Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 11.69 | 18.25 | UnitedHealth |
| Price-to-Book Ratio | 2.58 | 1.07 | CVS Health |
| Debt-to-Equity Ratio | 75.58 | 106.67 | UnitedHealth |
| PEG Ratio | -0.66 | 10.11 | UnitedHealth |
| EV/EBITDA | 8.76 | 10.81 | UnitedHealth |
| Profit Margin (TTM) | 5.04% | 1.18% | UnitedHealth |
| Operating Margin (TTM) | 4.61% | 2.80% | UnitedHealth |
| EBITDA Margin (TTM) | 4.61% | 2.80% | UnitedHealth |
| Return on Equity | 21.65% | 5.88% | UnitedHealth |
| Return on Assets (TTM) | 6.46% | 2.29% | UnitedHealth |
| Free Cash Flow (TTM) | $20.71B | $6.33B | UnitedHealth |
| Dividend Yield | 2.05% | 3.01% | CVS Health |
| 1-Year Return | -47.37% | 17.57% | CVS Health |
| Price-to-Sales Ratio (TTM) | 0.58 | 0.22 | CVS Health |
| Enterprise Value | $294.13B | $151.01B | UnitedHealth |
| EV/Revenue Ratio | 0.70 | 0.39 | CVS Health |
| Gross Profit Margin (TTM) | 17.93% | 13.74% | UnitedHealth |
| Revenue per Share (TTM) | $462 | $305 | UnitedHealth |
| Earnings per Share (Diluted) | $23.10 | $3.59 | UnitedHealth |
| Beta (Stock Volatility) | 0.44 | 0.59 | UnitedHealth |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
UnitedHealth vs CVS Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| UnitedHealth | 11.98% | 21.22% | 4.26% | 10.86% | -39.26% | -39.72% |
| CVS Health | 2.80% | 4.67% | 7.29% | 13.44% | 4.62% | 55.13% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| UnitedHealth | -47.37% | -44.56% | -3.22% | 161.45% | 861.75% | 494.00% |
| CVS Health | 17.57% | -34.07% | 7.29% | -32.88% | 145.09% | 137.78% |
Performance & Financial Health Analysis: UnitedHealth vs CVS Health
| Metric | UNH | CVS |
|---|---|---|
| Market Information | ||
| Market Cap | $244.53B | $83.09B |
| Market Cap Category | Mega cap | Large cap |
| 10 Day Avg. Volume | 16,995,752 | 9,761,131 |
| 90 Day Avg. Volume | 15,668,924 | 8,177,547 |
| Last Close | $304.01 | $68.60 |
| 52 Week Range | $234.60 - $630.73 | $43.56 - $72.51 |
| % from 52W High | -51.80% | -5.39% |
| All-Time High | $630.73 (Nov 11, 2024) | $113.65 (Jul 27, 2015) |
| % from All-Time High | -51.80% | -39.64% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.08% |
| Quarterly Earnings Growth | -0.19% | -0.42% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.01% |
| Operating Margin (TTM) | 0.05% | 0.03% |
| Return on Equity (TTM) | 0.22% | 0.06% |
| Debt to Equity (MRQ) | 75.58 | 106.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $104.67 | $61.07 |
| Cash per Share (MRQ) | $35.36 | $11.18 |
| Operating Cash Flow (TTM) | $28.96B | $7.57B |
| Levered Free Cash Flow (TTM) | $27.21B | $5.83B |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.05% | 3.01% |
| Last 12-Month Dividend | $6.30 | $2.01 |
Valuation & Enterprise Metrics Analysis: UnitedHealth vs CVS Health
| Metric | UNH | CVS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 11.69 | 18.25 |
| Forward P/E | 9.03 | 10.11 |
| PEG Ratio | -0.66 | 10.11 |
| Price to Sales (TTM) | 0.58 | 0.22 |
| Price to Book (MRQ) | 2.58 | 1.07 |
| Market Capitalization | ||
| Market Capitalization | $244.53B | $83.09B |
| Enterprise Value | $294.13B | $151.01B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.70 | 0.39 |
| Enterprise to EBITDA | 8.76 | 10.81 |
| Risk & Other Metrics | ||
| Beta | 0.44 | 0.59 |
| Book Value per Share (MRQ) | $104.67 | $61.07 |
Financial Statements Comparison: UnitedHealth vs CVS Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | UNH | CVS |
|---|---|---|
| Revenue/Sales | $111.62B | $94.59B |
| Cost of Goods Sold | $91.60B | $80.19B |
| Gross Profit | $20.01B | $14.40B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $5.15B | $3.37B |
| EBITDA | $6.23B | $4.56B |
| Pre-Tax Income | $4.08B | $2.62B |
| Income Tax | $510.00M | $835.00M |
| Net Income (Profit) | $3.57B | $1.78B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | UNH | CVS |
|---|---|---|
| Cash & Equivalents | $30.72B | $10.08B |
| Total Current Assets | $96.29B | $73.19B |
| Total Current Liabilities | $113.47B | $88.96B |
| Long-Term Debt | $71.29B | $73.63B |
| Total Shareholders Equity | $105.17B | $77.11B |
| Retained Earnings | $97.93B | $63.77B |
| Property, Plant & Equipment | N/A | $28.56B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | UNH | CVS |
|---|---|---|
| Operating Cash Flow | $2.45B | $3.96B |
| Capital Expenditures | $-898.00M | $-743.00M |
| Free Cash Flow | $4.56B | $3.81B |
| Debt Repayment | $0 | $-743.00M |
| Common Stock Repurchase | $-3.00B | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | UNH | CVS |
|---|---|---|
| Shares Short | 15.23M | 15.65M |
| Short Ratio | 0.98 | 1.83 |
| Short % of Float | 0.02% | 0.01% |
| Average Daily Volume (10 Day) | 16,995,752 | 9,761,131 |
| Average Daily Volume (90 Day) | 15,668,924 | 8,177,547 |
| Shares Outstanding | 915.00M | 1.26B |
| Float Shares | 903.00M | 1.27B |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 0.88% | 0.87% |
Dividend Analysis & Yield Comparison: UnitedHealth vs CVS Health
| Metric | UNH | CVS |
|---|---|---|
| Last 12-Month Dividend | $6.30 | $2.01 |
| Last 12-Month Dividend Yield | 2.05% | 3.01% |
| 3-Year Avg Annual Dividend | $6.33 | $2.28 |
| 3-Year Avg Dividend Yield | 0.38% | 0.87% |
| 3-Year Total Dividends | $18.99 | $6.85 |
| Ex-Dividend Date | Mar 10, 2025 | Apr 22, 2025 |